Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients
Crossref DOI link: https://doi.org/10.1007/s00432-018-2801-7
Published Online: 2018-11-24
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Jia
Wu, Nan
Lv, Chao
Yan, Shi
Yang, Yue http://orcid.org/0000-0001-7046-0027
Text and Data Mining valid from 2018-11-24
Article History
Received: 22 February 2018
Accepted: 19 November 2018
First Online: 24 November 2018